Pet Veterinary Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product Type (Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics, Sedatives, Others); Route of Administration (Oral, Parenteral, Topical); End User (Veterinary Hospitals, Veterinary Clinics, Drug Stores)
Report Code: TIPRE00015287 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Pet veterinary drug is the division of medicine that deals with the prevention, disorder, and injury in animals and diagnosis and treatment of disease. Among pet veterinary drugs, some are similar to human medications. The development has created several specialties within the field, including areas of expertise such as internal medicine, ophthalmology, radiology, surgery, dermatology anesthesiology, neurology, oncology, and emergency care.
MARKET DYNAMICS
The pet veterinary drugs market is driving due to rapidly increasing pet adoptions, re-occurrence of animal diseases. However, costs related to pet veterinary drugs, lack of routine checkups, and preventive measures for pets in numerous households are expected to hamper the global pet veterinary drugs market. Moreover, the increasing focus of industry players in emerging nations and growing pet expenditure provides opportunities in the market.
MARKET SCOPE
The "Pet Veterinary Drugs Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pet veterinary drugs market with detailed market segmentation by product type, route of administration and end user. The pet veterinary drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Pet veterinary drugs market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The pet veterinary drugs market is segmented on the basis of product type, route of administration and end user. Based on product type, the market is segmented as anti-infectives, anti-inflammatory, parasiticides, analgesics, sedatives, and others. Based on route of administration, the market is segmented as oral, parenteral, and topical. Based on end user, the market is segmented as veterinary hospitals, veterinary clinics, and drug stores.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pet veterinary drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pet veterinary drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pet veterinary drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pet veterinary drugs market in these regions.
The report covers key developments in the pet veterinary drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pet veterinary drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for pet veterinary drugs in the global market. Below mentioned is the list of few companies engaged in the pet veterinary drugs market.
The report also includes the profiles of key players in pet veterinary drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Pet veterinary drug is the division of medicine that deals with the prevention, disorder, and injury in animals and diagnosis and treatment of disease. Among pet veterinary drugs, some are similar to human medications. The development has created several specialties within the field, including areas of expertise such as internal medicine, ophthalmology, radiology, surgery, dermatology anesthesiology, neurology, oncology, and emergency care.
MARKET DYNAMICS
The pet veterinary drugs market is driving due to rapidly increasing pet adoptions, re-occurrence of animal diseases. However, costs related to pet veterinary drugs, lack of routine checkups, and preventive measures for pets in numerous households are expected to hamper the global pet veterinary drugs market. Moreover, the increasing focus of industry players in emerging nations and growing pet expenditure provides opportunities in the market.
MARKET SCOPE
The "Pet Veterinary Drugs Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pet veterinary drugs market with detailed market segmentation by product type, route of administration and end user. The pet veterinary drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Pet veterinary drugs market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The pet veterinary drugs market is segmented on the basis of product type, route of administration and end user. Based on product type, the market is segmented as anti-infectives, anti-inflammatory, parasiticides, analgesics, sedatives, and others. Based on route of administration, the market is segmented as oral, parenteral, and topical. Based on end user, the market is segmented as veterinary hospitals, veterinary clinics, and drug stores.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pet veterinary drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pet veterinary drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pet veterinary drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pet veterinary drugs market in these regions.
The report covers key developments in the pet veterinary drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pet veterinary drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for pet veterinary drugs in the global market. Below mentioned is the list of few companies engaged in the pet veterinary drugs market.
The report also includes the profiles of key players in pet veterinary drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Boehringer Ingelheim International GmbH
- Zoetis Animal Healthcare
- Bayer AG
- Merck Animal Health
- Elanco Animal Health Inc.
- Virbac Group
- Ceva
- Dechra Pharmaceuticals Plc
- Vetoquinol
- Orion Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pet Veterinary Drugs Market - By Product Type
1.3.2 Pet Veterinary Drugs Market - By Route of Administration
1.3.3 Pet Veterinary Drugs Market - By End User
1.3.4 Pet Veterinary Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PET VETERINARY DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PET VETERINARY DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PET VETERINARY DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. PET VETERINARY DRUGS - GLOBAL MARKET OVERVIEW
6.2. PET VETERINARY DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PET VETERINARY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTI-INFECTIVES
7.3.1. Overview
7.3.2. Anti-Infectives Market Forecast and Analysis
7.4. ANTI-INFLAMMATORY
7.4.1. Overview
7.4.2. Anti-Inflammatory Market Forecast and Analysis
7.5. PARASITICIDES
7.5.1. Overview
7.5.2. Parasiticides Market Forecast and Analysis
7.6. ANALGESICS
7.6.1. Overview
7.6.2. Analgesics Market Forecast and Analysis
7.7. SEDATIVES
7.7.1. Overview
7.7.2. Sedatives Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. PET VETERINARY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. PARENTERAL
8.4.1. Overview
8.4.2. Parenteral Market Forecast and Analysis
8.5. TOPICAL
8.5.1. Overview
8.5.2. Topical Market Forecast and Analysis
9. PET VETERINARY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. VETERINARY HOSPITALS
9.3.1. Overview
9.3.2. Veterinary Hospitals Market Forecast and Analysis
9.4. VETERINARY CLINICS
9.4.1. Overview
9.4.2. Veterinary Clinics Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
10. PET VETERINARY DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pet Veterinary Drugs Market Overview
10.1.2 North America Pet Veterinary Drugs Market Forecasts and Analysis
10.1.3 North America Pet Veterinary Drugs Market Forecasts and Analysis - By Product Type
10.1.4 North America Pet Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Pet Veterinary Drugs Market Forecasts and Analysis - By End User
10.1.6 North America Pet Veterinary Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pet Veterinary Drugs Market
10.1.6.1.1 United States Pet Veterinary Drugs Market by Product Type
10.1.6.1.2 United States Pet Veterinary Drugs Market by Route of Administration
10.1.6.1.3 United States Pet Veterinary Drugs Market by End User
10.1.6.2 Canada Pet Veterinary Drugs Market
10.1.6.2.1 Canada Pet Veterinary Drugs Market by Product Type
10.1.6.2.2 Canada Pet Veterinary Drugs Market by Route of Administration
10.1.6.2.3 Canada Pet Veterinary Drugs Market by End User
10.1.6.3 Mexico Pet Veterinary Drugs Market
10.1.6.3.1 Mexico Pet Veterinary Drugs Market by Product Type
10.1.6.3.2 Mexico Pet Veterinary Drugs Market by Route of Administration
10.1.6.3.3 Mexico Pet Veterinary Drugs Market by End User
10.2. EUROPE
10.2.1 Europe Pet Veterinary Drugs Market Overview
10.2.2 Europe Pet Veterinary Drugs Market Forecasts and Analysis
10.2.3 Europe Pet Veterinary Drugs Market Forecasts and Analysis - By Product Type
10.2.4 Europe Pet Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Pet Veterinary Drugs Market Forecasts and Analysis - By End User
10.2.6 Europe Pet Veterinary Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pet Veterinary Drugs Market
10.2.6.1.1 Germany Pet Veterinary Drugs Market by Product Type
10.2.6.1.2 Germany Pet Veterinary Drugs Market by Route of Administration
10.2.6.1.3 Germany Pet Veterinary Drugs Market by End User
10.2.6.2 France Pet Veterinary Drugs Market
10.2.6.2.1 France Pet Veterinary Drugs Market by Product Type
10.2.6.2.2 France Pet Veterinary Drugs Market by Route of Administration
10.2.6.2.3 France Pet Veterinary Drugs Market by End User
10.2.6.3 Italy Pet Veterinary Drugs Market
10.2.6.3.1 Italy Pet Veterinary Drugs Market by Product Type
10.2.6.3.2 Italy Pet Veterinary Drugs Market by Route of Administration
10.2.6.3.3 Italy Pet Veterinary Drugs Market by End User
10.2.6.4 Spain Pet Veterinary Drugs Market
10.2.6.4.1 Spain Pet Veterinary Drugs Market by Product Type
10.2.6.4.2 Spain Pet Veterinary Drugs Market by Route of Administration
10.2.6.4.3 Spain Pet Veterinary Drugs Market by End User
10.2.6.5 United Kingdom Pet Veterinary Drugs Market
10.2.6.5.1 United Kingdom Pet Veterinary Drugs Market by Product Type
10.2.6.5.2 United Kingdom Pet Veterinary Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom Pet Veterinary Drugs Market by End User
10.2.6.6 Rest of Europe Pet Veterinary Drugs Market
10.2.6.6.1 Rest of Europe Pet Veterinary Drugs Market by Product Type
10.2.6.6.2 Rest of Europe Pet Veterinary Drugs Market by Route of Administration
10.2.6.6.3 Rest of Europe Pet Veterinary Drugs Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pet Veterinary Drugs Market Overview
10.3.2 Asia-Pacific Pet Veterinary Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Pet Veterinary Drugs Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Pet Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Pet Veterinary Drugs Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Pet Veterinary Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pet Veterinary Drugs Market
10.3.6.1.1 Australia Pet Veterinary Drugs Market by Product Type
10.3.6.1.2 Australia Pet Veterinary Drugs Market by Route of Administration
10.3.6.1.3 Australia Pet Veterinary Drugs Market by End User
10.3.6.2 China Pet Veterinary Drugs Market
10.3.6.2.1 China Pet Veterinary Drugs Market by Product Type
10.3.6.2.2 China Pet Veterinary Drugs Market by Route of Administration
10.3.6.2.3 China Pet Veterinary Drugs Market by End User
10.3.6.3 India Pet Veterinary Drugs Market
10.3.6.3.1 India Pet Veterinary Drugs Market by Product Type
10.3.6.3.2 India Pet Veterinary Drugs Market by Route of Administration
10.3.6.3.3 India Pet Veterinary Drugs Market by End User
10.3.6.4 Japan Pet Veterinary Drugs Market
10.3.6.4.1 Japan Pet Veterinary Drugs Market by Product Type
10.3.6.4.2 Japan Pet Veterinary Drugs Market by Route of Administration
10.3.6.4.3 Japan Pet Veterinary Drugs Market by End User
10.3.6.5 South Korea Pet Veterinary Drugs Market
10.3.6.5.1 South Korea Pet Veterinary Drugs Market by Product Type
10.3.6.5.2 South Korea Pet Veterinary Drugs Market by Route of Administration
10.3.6.5.3 South Korea Pet Veterinary Drugs Market by End User
10.3.6.6 Rest of Asia-Pacific Pet Veterinary Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Pet Veterinary Drugs Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Pet Veterinary Drugs Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Pet Veterinary Drugs Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pet Veterinary Drugs Market Overview
10.4.2 Middle East and Africa Pet Veterinary Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Pet Veterinary Drugs Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Pet Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Pet Veterinary Drugs Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Pet Veterinary Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pet Veterinary Drugs Market
10.4.6.1.1 South Africa Pet Veterinary Drugs Market by Product Type
10.4.6.1.2 South Africa Pet Veterinary Drugs Market by Route of Administration
10.4.6.1.3 South Africa Pet Veterinary Drugs Market by End User
10.4.6.2 Saudi Arabia Pet Veterinary Drugs Market
10.4.6.2.1 Saudi Arabia Pet Veterinary Drugs Market by Product Type
10.4.6.2.2 Saudi Arabia Pet Veterinary Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia Pet Veterinary Drugs Market by End User
10.4.6.3 U.A.E Pet Veterinary Drugs Market
10.4.6.3.1 U.A.E Pet Veterinary Drugs Market by Product Type
10.4.6.3.2 U.A.E Pet Veterinary Drugs Market by Route of Administration
10.4.6.3.3 U.A.E Pet Veterinary Drugs Market by End User
10.4.6.4 Rest of Middle East and Africa Pet Veterinary Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Pet Veterinary Drugs Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Pet Veterinary Drugs Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Pet Veterinary Drugs Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pet Veterinary Drugs Market Overview
10.5.2 South and Central America Pet Veterinary Drugs Market Forecasts and Analysis
10.5.3 South and Central America Pet Veterinary Drugs Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Pet Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Pet Veterinary Drugs Market Forecasts and Analysis - By End User
10.5.6 South and Central America Pet Veterinary Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pet Veterinary Drugs Market
10.5.6.1.1 Brazil Pet Veterinary Drugs Market by Product Type
10.5.6.1.2 Brazil Pet Veterinary Drugs Market by Route of Administration
10.5.6.1.3 Brazil Pet Veterinary Drugs Market by End User
10.5.6.2 Argentina Pet Veterinary Drugs Market
10.5.6.2.1 Argentina Pet Veterinary Drugs Market by Product Type
10.5.6.2.2 Argentina Pet Veterinary Drugs Market by Route of Administration
10.5.6.2.3 Argentina Pet Veterinary Drugs Market by End User
10.5.6.3 Rest of South and Central America Pet Veterinary Drugs Market
10.5.6.3.1 Rest of South and Central America Pet Veterinary Drugs Market by Product Type
10.5.6.3.2 Rest of South and Central America Pet Veterinary Drugs Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Pet Veterinary Drugs Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PET VETERINARY DRUGS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PET VETERINARY DRUGS MARKET, KEY COMPANY PROFILES
13.1. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ZOETIS ANIMAL HEALTHCARE
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BAYER AG
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. MERCK ANIMAL HEALTH
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ELANCO ANIMAL HEALTH INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. VIRBAC GROUP
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. CEVA
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. DECHRA PHARMACEUTICALS PLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. VETOQUINOL
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ORION CORPORATION
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pet Veterinary Drugs Market - By Product Type
1.3.2 Pet Veterinary Drugs Market - By Route of Administration
1.3.3 Pet Veterinary Drugs Market - By End User
1.3.4 Pet Veterinary Drugs Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PET VETERINARY DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PET VETERINARY DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PET VETERINARY DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. PET VETERINARY DRUGS - GLOBAL MARKET OVERVIEW
6.2. PET VETERINARY DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PET VETERINARY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTI-INFECTIVES
7.3.1. Overview
7.3.2. Anti-Infectives Market Forecast and Analysis
7.4. ANTI-INFLAMMATORY
7.4.1. Overview
7.4.2. Anti-Inflammatory Market Forecast and Analysis
7.5. PARASITICIDES
7.5.1. Overview
7.5.2. Parasiticides Market Forecast and Analysis
7.6. ANALGESICS
7.6.1. Overview
7.6.2. Analgesics Market Forecast and Analysis
7.7. SEDATIVES
7.7.1. Overview
7.7.2. Sedatives Market Forecast and Analysis
7.8. OTHERS
7.8.1. Overview
7.8.2. Others Market Forecast and Analysis
8. PET VETERINARY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. PARENTERAL
8.4.1. Overview
8.4.2. Parenteral Market Forecast and Analysis
8.5. TOPICAL
8.5.1. Overview
8.5.2. Topical Market Forecast and Analysis
9. PET VETERINARY DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. VETERINARY HOSPITALS
9.3.1. Overview
9.3.2. Veterinary Hospitals Market Forecast and Analysis
9.4. VETERINARY CLINICS
9.4.1. Overview
9.4.2. Veterinary Clinics Market Forecast and Analysis
9.5. DRUG STORES
9.5.1. Overview
9.5.2. Drug Stores Market Forecast and Analysis
10. PET VETERINARY DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pet Veterinary Drugs Market Overview
10.1.2 North America Pet Veterinary Drugs Market Forecasts and Analysis
10.1.3 North America Pet Veterinary Drugs Market Forecasts and Analysis - By Product Type
10.1.4 North America Pet Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Pet Veterinary Drugs Market Forecasts and Analysis - By End User
10.1.6 North America Pet Veterinary Drugs Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pet Veterinary Drugs Market
10.1.6.1.1 United States Pet Veterinary Drugs Market by Product Type
10.1.6.1.2 United States Pet Veterinary Drugs Market by Route of Administration
10.1.6.1.3 United States Pet Veterinary Drugs Market by End User
10.1.6.2 Canada Pet Veterinary Drugs Market
10.1.6.2.1 Canada Pet Veterinary Drugs Market by Product Type
10.1.6.2.2 Canada Pet Veterinary Drugs Market by Route of Administration
10.1.6.2.3 Canada Pet Veterinary Drugs Market by End User
10.1.6.3 Mexico Pet Veterinary Drugs Market
10.1.6.3.1 Mexico Pet Veterinary Drugs Market by Product Type
10.1.6.3.2 Mexico Pet Veterinary Drugs Market by Route of Administration
10.1.6.3.3 Mexico Pet Veterinary Drugs Market by End User
10.2. EUROPE
10.2.1 Europe Pet Veterinary Drugs Market Overview
10.2.2 Europe Pet Veterinary Drugs Market Forecasts and Analysis
10.2.3 Europe Pet Veterinary Drugs Market Forecasts and Analysis - By Product Type
10.2.4 Europe Pet Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Pet Veterinary Drugs Market Forecasts and Analysis - By End User
10.2.6 Europe Pet Veterinary Drugs Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pet Veterinary Drugs Market
10.2.6.1.1 Germany Pet Veterinary Drugs Market by Product Type
10.2.6.1.2 Germany Pet Veterinary Drugs Market by Route of Administration
10.2.6.1.3 Germany Pet Veterinary Drugs Market by End User
10.2.6.2 France Pet Veterinary Drugs Market
10.2.6.2.1 France Pet Veterinary Drugs Market by Product Type
10.2.6.2.2 France Pet Veterinary Drugs Market by Route of Administration
10.2.6.2.3 France Pet Veterinary Drugs Market by End User
10.2.6.3 Italy Pet Veterinary Drugs Market
10.2.6.3.1 Italy Pet Veterinary Drugs Market by Product Type
10.2.6.3.2 Italy Pet Veterinary Drugs Market by Route of Administration
10.2.6.3.3 Italy Pet Veterinary Drugs Market by End User
10.2.6.4 Spain Pet Veterinary Drugs Market
10.2.6.4.1 Spain Pet Veterinary Drugs Market by Product Type
10.2.6.4.2 Spain Pet Veterinary Drugs Market by Route of Administration
10.2.6.4.3 Spain Pet Veterinary Drugs Market by End User
10.2.6.5 United Kingdom Pet Veterinary Drugs Market
10.2.6.5.1 United Kingdom Pet Veterinary Drugs Market by Product Type
10.2.6.5.2 United Kingdom Pet Veterinary Drugs Market by Route of Administration
10.2.6.5.3 United Kingdom Pet Veterinary Drugs Market by End User
10.2.6.6 Rest of Europe Pet Veterinary Drugs Market
10.2.6.6.1 Rest of Europe Pet Veterinary Drugs Market by Product Type
10.2.6.6.2 Rest of Europe Pet Veterinary Drugs Market by Route of Administration
10.2.6.6.3 Rest of Europe Pet Veterinary Drugs Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pet Veterinary Drugs Market Overview
10.3.2 Asia-Pacific Pet Veterinary Drugs Market Forecasts and Analysis
10.3.3 Asia-Pacific Pet Veterinary Drugs Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Pet Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Pet Veterinary Drugs Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Pet Veterinary Drugs Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pet Veterinary Drugs Market
10.3.6.1.1 Australia Pet Veterinary Drugs Market by Product Type
10.3.6.1.2 Australia Pet Veterinary Drugs Market by Route of Administration
10.3.6.1.3 Australia Pet Veterinary Drugs Market by End User
10.3.6.2 China Pet Veterinary Drugs Market
10.3.6.2.1 China Pet Veterinary Drugs Market by Product Type
10.3.6.2.2 China Pet Veterinary Drugs Market by Route of Administration
10.3.6.2.3 China Pet Veterinary Drugs Market by End User
10.3.6.3 India Pet Veterinary Drugs Market
10.3.6.3.1 India Pet Veterinary Drugs Market by Product Type
10.3.6.3.2 India Pet Veterinary Drugs Market by Route of Administration
10.3.6.3.3 India Pet Veterinary Drugs Market by End User
10.3.6.4 Japan Pet Veterinary Drugs Market
10.3.6.4.1 Japan Pet Veterinary Drugs Market by Product Type
10.3.6.4.2 Japan Pet Veterinary Drugs Market by Route of Administration
10.3.6.4.3 Japan Pet Veterinary Drugs Market by End User
10.3.6.5 South Korea Pet Veterinary Drugs Market
10.3.6.5.1 South Korea Pet Veterinary Drugs Market by Product Type
10.3.6.5.2 South Korea Pet Veterinary Drugs Market by Route of Administration
10.3.6.5.3 South Korea Pet Veterinary Drugs Market by End User
10.3.6.6 Rest of Asia-Pacific Pet Veterinary Drugs Market
10.3.6.6.1 Rest of Asia-Pacific Pet Veterinary Drugs Market by Product Type
10.3.6.6.2 Rest of Asia-Pacific Pet Veterinary Drugs Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Pet Veterinary Drugs Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pet Veterinary Drugs Market Overview
10.4.2 Middle East and Africa Pet Veterinary Drugs Market Forecasts and Analysis
10.4.3 Middle East and Africa Pet Veterinary Drugs Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Pet Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Pet Veterinary Drugs Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Pet Veterinary Drugs Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pet Veterinary Drugs Market
10.4.6.1.1 South Africa Pet Veterinary Drugs Market by Product Type
10.4.6.1.2 South Africa Pet Veterinary Drugs Market by Route of Administration
10.4.6.1.3 South Africa Pet Veterinary Drugs Market by End User
10.4.6.2 Saudi Arabia Pet Veterinary Drugs Market
10.4.6.2.1 Saudi Arabia Pet Veterinary Drugs Market by Product Type
10.4.6.2.2 Saudi Arabia Pet Veterinary Drugs Market by Route of Administration
10.4.6.2.3 Saudi Arabia Pet Veterinary Drugs Market by End User
10.4.6.3 U.A.E Pet Veterinary Drugs Market
10.4.6.3.1 U.A.E Pet Veterinary Drugs Market by Product Type
10.4.6.3.2 U.A.E Pet Veterinary Drugs Market by Route of Administration
10.4.6.3.3 U.A.E Pet Veterinary Drugs Market by End User
10.4.6.4 Rest of Middle East and Africa Pet Veterinary Drugs Market
10.4.6.4.1 Rest of Middle East and Africa Pet Veterinary Drugs Market by Product Type
10.4.6.4.2 Rest of Middle East and Africa Pet Veterinary Drugs Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Pet Veterinary Drugs Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pet Veterinary Drugs Market Overview
10.5.2 South and Central America Pet Veterinary Drugs Market Forecasts and Analysis
10.5.3 South and Central America Pet Veterinary Drugs Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Pet Veterinary Drugs Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Pet Veterinary Drugs Market Forecasts and Analysis - By End User
10.5.6 South and Central America Pet Veterinary Drugs Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pet Veterinary Drugs Market
10.5.6.1.1 Brazil Pet Veterinary Drugs Market by Product Type
10.5.6.1.2 Brazil Pet Veterinary Drugs Market by Route of Administration
10.5.6.1.3 Brazil Pet Veterinary Drugs Market by End User
10.5.6.2 Argentina Pet Veterinary Drugs Market
10.5.6.2.1 Argentina Pet Veterinary Drugs Market by Product Type
10.5.6.2.2 Argentina Pet Veterinary Drugs Market by Route of Administration
10.5.6.2.3 Argentina Pet Veterinary Drugs Market by End User
10.5.6.3 Rest of South and Central America Pet Veterinary Drugs Market
10.5.6.3.1 Rest of South and Central America Pet Veterinary Drugs Market by Product Type
10.5.6.3.2 Rest of South and Central America Pet Veterinary Drugs Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Pet Veterinary Drugs Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PET VETERINARY DRUGS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Rest of the World
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PET VETERINARY DRUGS MARKET, KEY COMPANY PROFILES
13.1. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ZOETIS ANIMAL HEALTHCARE
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BAYER AG
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. MERCK ANIMAL HEALTH
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. ELANCO ANIMAL HEALTH INC.
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. VIRBAC GROUP
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. CEVA
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. DECHRA PHARMACEUTICALS PLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. VETOQUINOL
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ORION CORPORATION
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies
1. Boehringer Ingelheim International GmbH
2. Zoetis Animal Healthcare
3. Bayer AG
4. Merck Animal Health
5. Elanco Animal Health Inc.
6. Virbac Group
7. Ceva
8. Dechra Pharmaceuticals Plc
9. Vetoquinol
10. Orion Corporation
1. Boehringer Ingelheim International GmbH
2. Zoetis Animal Healthcare
3. Bayer AG
4. Merck Animal Health
5. Elanco Animal Health Inc.
6. Virbac Group
7. Ceva
8. Dechra Pharmaceuticals Plc
9. Vetoquinol
10. Orion Corporation